Isolation of rare circulating tumour cells in cancer patients by microchip technologySunitha Nagrath, Mehmet Toner, Lecia V. Sequist et al.|Nature|2007Cited by 3.5k
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast CancerMelinda L. Telli, Andrea L. Richardson, Steven J. Isakoff et al.|Clinical Cancer Research|2016Cited by 1.2k
Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast CancerDaniel P. Silver, Judy E. Garber, Andrea L. Richardson et al.|Journal of Clinical Oncology|2010Cited by 983
Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging AgentsNicolai J. Birkbak, Andrea L. Richardson, Zhigang C. Wang et al.|Cancer Discovery|2012Cited by 684
Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trialLaura M. Spring, Aditya Bardia, Sara M. Tolaney et al.|Annals of Oncology|2023Cited by 77